prolaio eVO2peak Module vs VX1+
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if your primary need is to longitudinally monitor and estimate peak oxygen consumption (eVO2peak) for cardiovascular research or long-term patient care. This tool is ideal for leveraging real-world patient data from remote wearable sensors to gain insights into functional capacity and cardiovascular health over time.
View prolaio eVO2peak Module →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist seeking real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation or tachycardia. This software is specifically designed to identify abnormal electrograms and provide crucial insights directly within the EP lab, enhancing procedural guidance and efficiency.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | VX1+ |
|---|---|---|
| Deployment | Cloud | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
prolaio eVO2peak ModuleProlaio eVO2peak Module is cloud-based and processes remote sensor data, implying a simpler deployment and data input process. It also offers a patient-facing mobile app for data collection, making it accessible to a broader user base beyond specialists. While VX1+ has a simple interface for electrophysiologists, Tool A's broader accessibility for data input gives it an edge in general usability.
Clinical Value
VX1+Volta Medical's VX1+ provides real-time AI-driven insights during complex cardiac ablation procedures, directly assisting electrophysiologists in identifying abnormal electrograms. Clinical trials, such as TAILORED-AF and RESTART, have demonstrated its superiority in improving patient outcomes, including higher freedom from atrial fibrillation. While Prolaio eVO2peak Module offers valuable prognostic information, VX1+'s direct impact on interventional procedural success and patient outcomes is more significant.
Pricing & Value
TieBoth Prolaio eVO2peak Module and Volta Medical VX1+ explicitly state that pricing information is not publicly available and requires direct contact. Without transparent pricing details for either product, it is impossible to conduct a direct comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
prolaio eVO2peak ModuleProlaio eVO2peak Module explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, which are critical for enterprise adoption in healthcare. While Volta Medical's VX1+ is FDA-cleared and integrates with existing EP systems, its HIPAA compliance and BAA availability are not explicitly stated in the initial facts, though its website indicates a commitment to compliance. Tool A's clear documentation of these compliance aspects provides a stronger foundation for enterprise readiness.
Innovation
VX1+Volta Medical's VX1+ offers highly innovative real-time AI guidance during complex cardiac ablation procedures, standardizing the identification of abnormal electrograms that were previously subject to high operator variability. This direct, real-time intervention in a high-stakes surgical environment represents a more profound advancement in clinical practice. Prolaio eVO2peak Module's use of AI for estimating VO2peak from wearables is innovative, but VX1+'s impact on interventional decision-making is arguably more groundbreaking.
Support & Docs
VX1+Volta Medical explicitly provides access to user manuals and instructions for use (IFU) for its VX1+ (also referred to as Volta AF-Xploreru2122 II) on its website, indicating readily available documentation for users. In contrast, the provided structured facts and web searches for Prolaio eVO2peak Module did not yield specific information regarding its customer support or documentation availability.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | VX1+ |
|---|---|---|
| Name | prolaio eVO2peak Module | VX1+ |
| Company | Prolaio | Volta Medical |
| Primary Function | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. | Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key Inputs | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. | Data from existing EP recording and 3D mapping systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system). |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Surgical AI |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and VX1+.